Pathology of Alzheimer's disease.

The fundamental pathophysiology of Alzheimer's disease remains poorly understood, but progress has been dramatic in description of the pathology at the molecular level. The characteristic Alzheimer amyloid derives, in part, by action of microglia, from a precursor protein that is well characterized at the protein and gene levels. The characteristic paired helical filaments contain phosphorylated tau proteins and perhaps other constituents. At the neurotransmitter level, Alzheimer's disease involves not only loss of cholinergic cells but of serotonergic and other neurotransmitter systems as well. Damage to mitochondria may play an important role in precipitating the cellular pathophysiology.

[1]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[2]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[3]  C. Geula,et al.  Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability , 1993, Annals of neurology.

[4]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[5]  A. Young,et al.  Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.

[6]  C. U. M. Smith,et al.  Elements of molecular neurobiology , 1989 .

[7]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[8]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[9]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[10]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[11]  B. Winblad,et al.  Tacrine restores cholinergic nicotinic receptors and glucose metabolism in alzheimer patients as visualized by positron emission tomography , 1992, Neurobiology of Aging.